i think its time, page-20

I'll be a lot happier if they are still buyers in the 80c to 1.50 range as that would confirm they know the long term prospects and are aware it is a dead set target of big pharma. I don't think they will balance the portfolio as it is just not their style when they research and find a good thing they stick with it until the value is extracted or the company changes. Hope they are on a winner as I win as well.